Harith Rajagopalan net worth and biography

Harith Rajagopalan Biography and Net Worth

CEO of Fractyl Health

Harith Rajagopalan, M.D., Ph.D., is Co-founder and CEO of Fractyl Health, having started the company while serving as an Entrepreneur-in-Residence at General Catalyst Partners.

Prior to founding Fractyl Health, Harith was an academic cardiologist and physician-scientist. He received his B.S. in chemistry from Stanford University and went on to obtain M.D. and Ph.D. degrees from Johns Hopkins School of Medicine. At Johns Hopkins, Harith did groundbreaking and award-winning research on intestinal cancers that was published in top medical journals including Nature and Science.

After medical school, Harith trained in internal medicine and clinical cardiology at Brigham and Women’s Hospital and completed a research fellowship at the Harvard Stem Cell Institute at Harvard Medical School.

What is Harith Rajagopalan's net worth?: The estimated net worth of Harith Rajagopalan is at least $400.99 thousand as of June 10th, 2026. Dr. Rajagopalan owns 540,557 shares of Fractyl Health stock worth more than $400,985 as of August 28th. This net worth estimate does not reflect any other investments that Dr. Rajagopalan may own. Learn More about Harith Rajagopalan's net worth.
How do I contact Harith Rajagopalan?: The corporate mailing address for Dr. Rajagopalan and other Fractyl Health executives is 17 Hartwell Avenue, Lexington, MA 02421, United States. Fractyl Health can also be reached via phone at 781-902-8800 and via email at [email protected]. Learn More on Harith Rajagopalan's contact information.
Has Harith Rajagopalan been buying or selling shares of Fractyl Health?: Harith Rajagopalan has not been actively trading shares of Fractyl Health in the last ninety days. Most recently, on Wednesday, June 10th, Harith Rajagopalan bought 25,000 shares of Fractyl Health stock. The stock was acquired at an average cost of $0.73 per share, with a total value of $18,250.00. Following the completion of the transaction, the chief executive officer now directly owns 540,557 shares of the company's stock, valued at $394,606.61. Learn More on Harith Rajagopalan's trading history.
Who are Fractyl Health's active insiders?: Fractyl Health's insider roster includes Harith Rajagopalan (CEO), and Ajay Royan (Director). Learn More on Fractyl Health's active insiders.
Are insiders buying or selling shares of Fractyl Health?: During the last twelve months, Fractyl Health insiders bought shares 6 times. They purchased a total of 181,909 shares worth more than $147,148.61. The most recent insider tranaction occured on June, 12th when Director Ajay Royan bought 23,000 shares worth more than $19,550.00. Insiders at Fractyl Health own 8.5% of the company. Learn More about insider trades at Fractyl Health.
Information on this page was last updated on 6/12/2026.

Harith Rajagopalan Insider Trading History at Fractyl Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/10/2026	Buy	25,000	$0.73	$18,250.00	540,557
12/4/2025	Buy	10,416	$1.92	$19,998.72	501,745
1/31/2025	Sell	90,972	$1.82	$165,569.04	491,329
11/11/2024	Sell	96,517	$2.47	$238,396.99	491,329

Harith Rajagopalan Buying and Selling Activity at Fractyl Health

Fractyl Health Company Overview

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.

Today's Range

Now: $0.74

$0.74

$0.76

50 Day Range

MA: $0.75

$0.66

$0.91

2 Week Range

Now: $0.74

$0.38

$2.45

Volume

56,479 shs

Average Volume

3,196,592 shs

Market Capitalization

$117.94 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.32